Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us ...

GSK has selected a liver disease drug candidate from its collaboration with Wave Life Sciences for further development, ...

Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, ...

Boehringer Ingelheim’s survodutide delivered average weight loss of up to 13.1% in a Phase 3 trial involving people with ...

Swedish biotech Atrogi says its oral drug ATR-258 increased lower-extremity muscle power by about 13% after eight weeks in a ...

In proceedings before the European Patent Office (EPO), applicants are required to „adapt“ the description to the claims of a ...

Qure’s shares fell about 40% in early trading on September 29 after its Huntington’s gene therapy missed statistical ...

Swedish biotech AnaCardio has raised €62.5 million to take its oral heart failure drug AC01 through Phase 2b, testing whether ...

AstraZeneca has agreed to invest $2 billion (€1.8 billion) in Summit Therapeutics and test its cancer drug ivonescimab ...

Aptadir Therapeutics has raised €40 million in seed funding to advance an RNA therapy designed to reactivate the gene ...

Danish biotech Breye Therapeutics has raised €67.5 million to advance an oral eye disease drug candidate into a Phase 2 ...

The 2025 AseBio Report shows a Spanish biotech ecosystem that is not only expanding, but attracting capital at a new scale: ...